Search

Using Multiple Technologies to Maximize Quality of Vision

I. Paul Singh, MD

Show Description +

In the age of interventional glaucoma, surgeons often must utilize multiple technologies to help reduce the glaucoma medication burden and maximize quality of vision. In this case, I. Paul Singh, MD, uses the Hydrus Microstent (Alcon), iDose TR (Glaukos), an enVista Aspire Toric IOL (Bausch + Lomb), and Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix).

Financial Disclosures: Consultant (Alcon, Bausch + Lomb, Glaukos)

Posted: 10/27/2025

Keywords:

Hydrus Microstent (Alcon)

•

iDose TR

Up Next

FLACS With Toric and iStent inject

FLACS With Toric and iStent inject

Blake Williamson, MD, MPH, MS

Targeted Placement of iStent Trabecular Micro-Bypass Stent (Glaukos)

Targeted Placement of iStent Trabecular Micro-Bypass Stent (Glaukos)

Eric Rosenberg, MD

Cataract Surgery Combined with Canaloplasty

Cataract Surgery Combined with Canaloplasty

Mahmoud A. Khaimi, MD

Needle Viscocanalostomy

Needle Viscocanalostomy

Eslam Ramadan, MD

Ahmed M4 Placement

Ahmed M4 Placement

Nathan Radcliffe MD

Hydrogel Sealant to Prevent Chamber Shallowing During Combined Phaco and Tube Shunt Insertion

Hydrogel Sealant to Prevent Chamber Shallowing During Combined Phaco and Tube Shunt Insertion

Ian Conner, MD

Supra-Tenons Baerveldt Glaucoma Drainage Device

Supra-Tenons Baerveldt Glaucoma Drainage Device

George Tanaka, MD

iStent Trabecular Microbypass Implantation Technique

iStent Trabecular Microbypass Implantation Technique

Ike K. Ahmed MD

Trabectome 180

Trabectome 180

Constance Okeke, MD, MSCE

New Directions for GT

New Directions for GT

Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC

Using Multiple Technologies to Maximize Quality of Vision

I. Paul Singh, MD

In the age of interventional glaucoma, surgeons often must utilize multiple technologies to help reduce the glaucoma medication burden and maximize quality of vision. In this case, I. Paul Singh, MD, uses the Hydrus Microstent (Alcon), iDose TR (Glaukos), an enVista Aspire Toric IOL (Bausch + Lomb), and Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix).

Financial Disclosures: Consultant (Alcon, Bausch + Lomb, Glaukos)

Posted: 10/27/2025

Keywords:

Hydrus Microstent (Alcon)

•

iDose TR

Please log in to leave a comment.

More in Glaucoma

Angle-Based MIGS for a Patient With Severe Glaucoma

Angle-Based MIGS for a Patient With Severe Glaucoma

John P. Berdahl, MD; Tanner J. Ferguson, MD; and Mitch Ibach, OD, FAAO

When a Minimally Invasive Procedure Fails

When a Minimally Invasive Procedure Fails

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Rachel G. Simpson, MD

Innovations in Glaucoma: The FYSX OPAP Device

Innovations in Glaucoma: The FYSX OPAP Device

I. Paul Singh, MD; and John P. Berdahl, MD

Challenging Cases: From PRK to IOP

Challenging Cases: From PRK to IOP

Radhika Rampat, MBBS, BSc(Hons), FRCOphth, and Marguerite B. McDonald, MD, FACS